Hyperspectral Endoscopy Imaging for the Early Detection of Precancerous Lesions in Average Risk Patients

Completed · Not applicable

Conditions studied: Patient

In brief

This trial studies whether hyperspectral endoscopy improves visualization of abnormal tissue in average risk patients during standard-of-care colonoscopies. Hyperspectral endoscopy is an emerging technique that has the potential to enable the signals from blood to be resolved from tissue-specific signals. Image-enhanced endoscopy may improve visualization of abnormal colonic tissue when compared to the standard-of-care high-definition white light endoscopy.

Key facts

Study ID

NCT04172493

Run by

OHSU Knight Cancer Institute

People needed

13

Starts

2019-08-26

Expected to finish

2020-01-27

Last updated by the study team

2020-05-08

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Ability to understand and the willingness to sign a written informed consent document
• Patients scheduled for a standard of care screening or surveillance colonoscopy

You may not qualify if…

• Any condition that, in the opinion of the investigator, precludes the patient from completion of the study procedure

Where it is running

• OHSU Knight Cancer Institute — Portland, Oregon, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.